and xylazine HC1 and remained elevated or continued to increase through 10 mm post-injection and then declined.
There were no mortalities in this study. Forty mg of yohimbine HC1 was used as an antagonist in eight elk, resulting in a mean (SD) recovery time of 14.0 (9.9) mm when administered intravenously (n = 6), and 124.7(9.5) mm when given intramuscularly (n = 2).
Recovery time varied with weight and dosage of yohimbine.
Elk given 2.1 to 2.6 mg/kg Telazol#{174} and 0.1 to 0.3 mg/kg xylazine HC1 responded to yohimbine HCI when administered intravenously. 
